INNV News Alert Innovus Pharmaceuticals Inc (INNV) 0.4900 09/19/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Innovus Pharmaceuticals Inc (INNV) 0.4900 $INNV

Innovus Pharma to market and distribute Sensum+ in the UK through Tramorgan
M2 - Thu Sep 18, 6:12AM CDT
Pharmaceutical company Innovus Pharmaceuticals (Other OTC:INNV) reported on Thursday the grant of an exclusive marketing sales and distribution right to its topical consumer care product Sensum+ in the UK to UK based Tramorgan.

Innovus Pharma Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+(TM) in the United Kingdom
GlobeNewswire - Thu Sep 18, 5:15AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCQB:INNV) announced today that it has entered into an exclusive marketing and distribution agreement with Tramorgan Limited, a British company ("Tramorgan" under which Innovus Pharma has granted to Tramorgan an exclusive marketing sales and distribution right to market and sell Innovus Pharma's topical consumer care product to increase penile sensitivity, Sensum+(TM) in the United Kingdom ("UK" . The agreement has an initial term of December 31, 2016 and can be extended thereafter for a twenty-four month period if Tramorgan has reached certain aggregate sales milestones. Pursuant to the agreement, Innovus Pharma is eligible to receive (a) up to $44 million dollars in sales milestone payments based on Tramorgan's attainment of certain levels of cumulative gross sales amounts plus (b) fifty percent (50%) royalties based on Tramorgan's net sales after distribution costs in the UK. The product will be available in 10ml multi-dose dispenser and single use packets.

Innovus Pharmaceuticals signs non-exclusive sampling, marketing and distribution agreement for Zestra in the US
M2 - Tue Sep 09, 6:42AM CDT
Innovus Pharmaceuticals (Other OTC:INNV), a provider of sexual dysfunction products, revealed on Monday the launch of an non-exclusive sampling, marketing and distribution agreement for Zestra with Bulu Bo.

Innovus Pharmaceuticals, Inc. (OTCQB:INNV), Exclusive Interview for Interlinked's Investment News Channel
PRWeb - Mon Sep 08, 6:05AM CDT
Innovus Pharma was one of the presenting companies at the recent FSXinterlinked Investment Conference, held at the Four Seasons Hotel in Westlake Village, California.

Innovus Pharma Expands US Distribution by Signing a Non-Exclusive Sampling and Distribution Agreement With Bulu Box(R) for Zestra(R) in the US
GlobeNewswire - Mon Sep 08, 5:00AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCQB:INNV), announced today it has entered into an non-exclusive sampling, marketing and distribution agreement with Bulu Box(R) ("Bulu Box" under which Bulu Box will add Zestra(R) as part of its monthly box to all current subscribers. In addition, Bulu Box will sell Zestra(R) 3 packettes box through its E-commerce platform in the US.

Innovus Pharma to Present at the 2014 Aegis Healthcare Conference in Las Vegas, NV and the See Thru Equity Fall Microcap Investor Conference in New York
GlobeNewswire - Thu Sep 04, 5:00AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, President & CEO of the Company is scheduled to present at the 2014 Aegis Healthcare Conference to be held September 10-13, 2014 at The Encore at Wynn Las Vegas. The Company's presentation will be on Friday, September 12th at 8:00 a.m. PDT.

Innovus Pharma to market and distribute Zestra for alternative markets through DanaLife ApS
M2 - Thu Aug 28, 6:56AM CDT
Pharmaceutical company Innovus Pharmaceuticals (Other OTC:INNV) Thursday executed an exclusive marketing and distribution agreement to grant the worldwide distribution right (excluding Canada) to market and sell its topical consumer care product Zestra in the alternative markets that excludes all medical and mainstream sales channels.

Innovus Pharma Signs Exclusive Marketing and Distribution Agreement With DanaLife ApS to Market and Distribute Zestra(R) for Alternative Markets
GlobeNewswire - Thu Aug 28, 5:21AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCQB:INNV) announced today it has entered into an exclusive marketing and distribution agreement with DanaLife ApS based in Denmark ("DanaLife" under which Innovus Pharma has granted to DanaLife an exclusive 18 month worldwide distribution right ( excluding Canada) , to market and sell Innovus Pharma's topical consumer care product to increase Female Sexual Arousal and Desire and Satisfaction, Zestra(R) for the alternative markets which excludes all medical and mainstream sales channels. The Company is in the process of negotiating commercial agreements with Pharmaceutical companies to promote the product in the medical and mainstream channels. Under the agreement the initial minimum orders are expected to be two hundred and fifty thousand US dollars. The terms of the agreement can be extended automatically by another 18 months if DanaLife meets certain minimum sales numbers.

Innovus Announces Formation of a Global Clinical Advisory Board to Support the Growth of Its Product Zestra(R)
GlobeNewswire - Thu Aug 21, 5:25AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or "Company" (www.innovuspharma.com) (OTCQB:INNV), announced today the formation of a Clinical Advisory Board made up of top key opinion leaders in the fields of gynecology and sexual health to support the continued growth of its Zestra product. The Clinical Advisory Board will work closely with the Innovus Pharma management team in addressing health authorities, outlining clinical protocols and surveys, as well as presenting Innovus Pharma at academic and industry meetings for its marketed and currently in-development products.

Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction
GlobeNewswire - Fri Aug 15, 5:00AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) a leader in over-the-counter ("OTC" and consumer care products for men and women's sexual dysfunction and health products announced today that its U.S. sales and marketing partner, Consortia Health, began recently the detailing of its Zestra(R) product clinically proven to enhance arousal, desire and satisfaction in women to gynecologists in 13 states. Consortia's 25 member sales force is composed of sales representatives and nurse practitioners. The sales force currently covers over 50% of the US population in the following U.S. states: Pennsylvania, Michigan, Nevada, Texas, Florida, Louisiana, Georgia, New York, New Jersey, Colorado, Washington, Utah, California, North Carolina and Arizona.

Innovus Pharma awarded higher line of credit of USD1.5m from CEO
M2 - Thu Aug 07, 7:03AM CDT
Sexual dysfunction company Innovus Pharmaceuticals (Other OTC:INNV) reported on Wednesday a rise in its line of credit with its president and CEO, Dr Bassam Damaj, to USD1.5m.

Innovus Pharma Secures Additional Funding by Increasing Its Line of Credit With Its Chief Executive Officer to $1.5M, Provides Quarter Update and Timing of Its 10-Q Filing
GlobeNewswire - Wed Aug 06, 5:01AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCQB:INNV) today announced that the Company increased its Line of Credit with Dr. Bassam Damaj, its President & CEO to a total of $1.5M. This added funding combined with the revenues from sales of commercial products both in the US and Canada, as well as from the new international partnerships the Company expects to announce this year, the Company believes, will provide a cash runway until Q2 2015. "My strong belief in the success of the Company and its commercial pipeline makes my commitment to Innovus unwavering," said Dr. Damaj, President & Chief Executive Officer of the Company.

Innovus Pharma to Present at the FSXinterlinked Financial Investment Conference in Westlake Village, CA
GlobeNewswire - Mon Jul 28, 1:32PM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, President & CEO of the Company will present to an audience of principals and key decision makers of broker/dealers and financial firms at the FSXinterlinked Financial Investment Conference to be held at the Four Season Westlake Village, California from July 30-August 2, 2014. The presentation will take place on Thursday, July 31, 2014 at 1:57pm.

Innovus Pharma Provides Corporate Update
ACCESSWIRE - Wed Jun 25, 5:29AM CDT
San Diego, CA / ACCESSWIRE / June 25, 2014 / Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company" (OTCBB: INNV) (http://www.innovuspharma.com/) announced today a corporate mid-year update covering Company activities, expected near-term events and comments on recent market conditions, as follows:

Personal Accident and Health Insurance in Greece, Key Trends and Opportunities to 2017
M2 - Wed Feb 26, 4:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/bjj4j7/personal_accident) has announced the addition of the "Personal Accident and Health Insurance in Greece, Key Trends and Opportunities to 2017" report to their offering. The Greek personal accident and health insurance segment accounted for the lowest share of premiums in the overall insurance industry in 2012. Demand for healthcare services and private health insurance increased during the review period (2008-2012), due to the inadequate service provided by public healthcare institutions and increasing per capita healthcare expenditure. Travel insurance accounted for the largest share of the segment. Growth in the category was supported by the introduction of low-cost airlines which increased the number of outbound tourists. Over the forecast period (2012-2017), the growth of the personal accident and health segment is expected to be driven by the travel and health insurance categories. Overall, the value of the Greek personal accident and health segment is expected to increase at a forecast-period compound annual growth rate (CAGR) of 5.5%. Key Topics Covered 1 Executive Summary 2 Introduction 3 Greek Insurance Industry Attractiveness 4 Personal Accident and Health Insurance Segment Outlook 5 Analysis by Distribution Channels 6 Porter's Five Forces Analysis - Greek Personal Accident and Health Insurance 7 Reinsurance Growth Dynamics and Challenges 8 Governance, Risk and Compliance 9 Competitive Landscape and Strategic Insights 10 Business Environment and Country Risk 11 Appendix Companies Mentioned - Eurolife - ING Greek Life Insurance - Metlife Alico For more information visit http://www.researchandmarkets.com/research/bj...l_accident About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Innovus Pharma reports market launch of EjectDelay in the US
M2 - Mon Feb 24, 7:02AM CST
Pharmaceuticals company Innovus Pharmaceuticals (Other OTC:INNV) disclosed on Friday the market availability of its over the counter (OTC) benzocaine-based topical premature ejaculation treatment, EjectDelay, in the US.

Innovus Pharma Announces Availability of EjectDelay(TM) for Premature Ejaculation in the United States
GlobeNewswire - Fri Feb 21, 5:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCBB:INNV) today announced the availability of its over the counter ("OTC" benzocaine-based topical premature ejaculation treatment EjectDelay(TM) in the United States ("U.S." .

Innovus Pharma to Exhibit Zestra(R) its Clinically Proven Product for Female Sexual Arousal and Desire at the International Society for the Study of Women's Sexual Health 2014 Annual Meeting in San Diego
GlobeNewswire - Thu Feb 20, 9:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTC BB:INNV) today announced that it will exhibit Zestra(R), its topical over the counter ("OTC" product for female sexual arousal and desire at the 2014 Annual International Society for the Study of Women's Sexual Health Meeting in San Diego from February 20-22, 2014.

Innovus Pharmaceuticals Inc elects Lynnette Dillen as CFO & EVP
M2 - Wed Feb 12, 4:23AM CST
Sexual dysfunction products company Innovus Pharmaceuticals Inc (Other OTC:INNV) revealed on Tuesday the appointment of Lynnette Dillen as executive vice president and chief financial officer for its finance, accounting, human resources, information technology and investor relations.

Innovus Pharma Expands Management Team and Adds Chief Financial Officer
GlobeNewswire - Tue Feb 11, 5:15AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCBB:INNV), today announced that Lynnette Dillen has joined the company as Executive Vice President and Chief Financial Officer with responsibility for finance, accounting, human resources, information technology and investor relations.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 13

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 148

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 221

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 199

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 67

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 106

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 53

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 83

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading

Top 5 Most Recently Viewed Articles

US Agriculture Partners with CeresAI for Enhanced Farming Insights

Updated Category News Views 168

US Agriculture and CeresAI: A Groundbreaking Collaboration In an innovative move, US Agriculture, LLC has teamed up with CeresAI to transform farmland monitoring through advanced technology. This partnership aims to leverage artificial intelligence for improved performance in agricultural investments by optimizing farmland management and reducing costs associated with...

Continue Reading
Infosys Launches New Zurich Office to Drive AI Innovations

Updated Category News Views 175

Infosys Expands Its Zurich Office for Enhanced Client Collaboration Infosys, a global trailblazer in digital services and consulting, has inaugurated its new office in Zurich, Switzerland, marking a pivotal moment in its 25-year journey within the Swiss market. With this move, Infosys not only relocates its Swiss headquarters to The Circle at Zurich Airport but also...

Continue Reading
SierraConstellation Partners Celebrates Significant Award Wins

Updated Category News Views 117

A Major Milestone for SierraConstellation Partners SierraConstellation Partners (“SCP”), a foremost interim management and advisory firm, has received several prestigious awards for its outstanding work in business restructuring. The Global M&A Network has recognized SCP's exemplary handling of both the sale of Vyera Pharmaceuticals' assets and the reorganization of...

Continue Reading
Kaltura's AI Innovations Recognized in Market Guide

Updated Category News Views 179

Kaltura's Recognition in the Industry Kaltura, a leader in AI Video Experience Cloud technology, has recently been acknowledged as a Representative Vendor in the Gartner Market Guide for Video Platform Services. This recognition is a testament to Kaltura's forward-thinking approach and its commitment to enhancing enterprise video solutions. The Importance of Video...

Continue Reading
Liberty Gold’s Annual Meeting Outcomes: New Leadership and Directions

Updated Category News Views 288

Liberty Gold Announces Annual General Meeting Results Vancouver, British Columbia – Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) has shared the outcomes of its recent Annual General Meeting (AGM) where shareholders participated in crucial decisions shaping the future leadership of the company. The AGM marked a significant moment for Liberty Gold as it transitions into a...

Continue Reading